Century Therapeutics, Inc. Research And Development Expense

Quick Answer

Century Therapeutics, Inc. reported Research And Development Expense of $75.65 million for the year ending 2021.

  • Century Therapeutics, Inc. showed an increase of +90.6% in Research And Development Expense from 2020 to 2021.
  • This data is from Century Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2022.
  • XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2021: $75.65 million | Fiscal year 2020: $39.68 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: